GlassScriptPhysician profile
Scott K Mayhew
NPI 1265439087
$882.84
in general payments reported to CMS, 2019-2025
20 companies · $442 in 2025
The $442 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.27 · 2020: $124 · 2021: $66.44 · 2022: $51.34 · 2023: $22.26 · 2024: $136 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $204.53 | 2019-2025 | Eterna |
| Medtronic, INC. | $200.58 | 2024-2025 | Kyphon Express II Kyphopak Tray, Inceptiv, Intellis Adaptivestim |
| Nalu Medical, INC. | $82.43 | 2025 | Nalu Neurostimulation System |
| Abbvie INC. | $46.36 | 2021-2024 | |
| Novo Nordisk INC | $42.50 | 2021-2024 | Wegovy |
| Painteq LLC | $41.84 | 2024 | Painteq |
| Spr Therapeutics, INC | $27.10 | 2025 | Sprint Pns System |
| Si-Bone, INC. | $23.10 | 2025 | |
| Globus Medical, INC. | $23.00 | 2025 | Senza |
| Hologic Sales and Service, LLC | $22.26 | 2023 | Aptima, Thinprep 2000 Processor |
| Sanofi-Aventis U.S. LLC | $21.28 | 2024 | |
| Collegium Pharmaceutical, INC. | $20.48 | 2025 | Belbuca |
| Boston Scientific Corporation | $20.26 | 2025 | General - Pain Management |
| Amgen INC. | $19.84 | 2024 | Krystexxa |
| Biotronik Nro, INC. | $19.21 | 2025 | Prospera |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.71 | 2025 | Tymlos |
| Daiichi Sankyo INC. | $14.58 | 2021 | |
| Merck Sharp & Dohme LLC | $14.22 | 2022 | |
| Medtronic USA, INC. | $12.50 | 2020 | |
| Arbor Pharmaceuticals, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mayhew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.